CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,491 enrolled
Drug / intervention
EP referred group +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03715790
NCT03715790N/ACompleted
CompareCT.gov

Improve Sudden Cardiac Arrest (SCA) Bridge Study

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Oct 23, 2018·Updated Jan 16, 2024

In Brief

An observational study evaluating EP referred group and Non-Referred group for Sudden Cardiac Arrest and Acute Myocardial Infarction. Completed, enrolled 1,491 participants across 52 sites in 16 countries.

Detailed Summary

The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSudden Cardiac Arrest, Acute Myocardial Infarction
CountriesBangladesh, Brunei, China, Egypt, India, Indonesia, Malaysia, Pakistan, Philippines, Saudi Arabia, Singapore, South Africa, South Korea, Taiwan, Thailand, Tunisia
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedOct 23, 2018
Enrollment StartNov 2, 2018
Primary CompletionApr 16, 2021
Study CompletionMay 27, 2021
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 7.7 years ago

Interventions

EP referred groupbehavioral

Referred for sudden cardiac death (SCD) risk stratification and management

Non-Referred groupbehavioral

Not referred for sudden cardiac death (SCD) risk stratification and management.